Choi Jimin相关文献与解析，生知库 | 链接生命科学的每一步

Jeong Sol, Cha Jae-Kook, Ahmed Wasim, Kim Jaewan, Kim Minsup, Hong Kyung Tae, Choi Wonji, Choi Sunjoo, Yoo Tae Hyeon, An Hyun-Ju, An Seung Chan, Lee Jaemin, Choi Jimin, Kim Sun-Young, Lee Jun-Seok, Lee Soonchul, Choi Junwon, Kim Jin Man

骨科研究

发表日期：2025

文献求助收藏

USP11 promotes colorectal cancer progression by stabilizing EGFR and TRAF6: a potential therapeutic target in EGFR- and TLR-driven tumorigenesis.

USP11 通过稳定 EGFR 和 TRAF6 促进结直肠癌进展：EGFR 和 TLR 驱动的肿瘤发生的潜在治疗靶点。

期刊:Cell Death & Disease

影响因子:9.6

doi:10.1038/s41419-025-08266-9

Shin Ji Hye, Kim Ji Young, Kim Seo Hyun, Kang Yeeun, Lee Ha-Jeong, Kim Mi-Jeong, Choi Jimin, Jeong Soo-Kyung, Park Si-On, Cho Yong Beom, Kim Kyeong Kyu, Shim Jae-Hyuck, Chun Eunyoung, Lee Ki-Young

PLA-Based Biodegradable Polymer from Synthesis to the Application

从合成到应用：基于PLA的生物降解聚合物

期刊:Polymers

影响因子:4.9

doi:10.3390/polym18010121

Wi, Junui; Choi, Jimin; Lee, Sang-Ho

发表日期：2025

文献求助收藏

Patient satisfaction and feasibility with a novel drug-injectable urethral catheter set for hyaluronic acid administration: a multicenter randomized trial

一种新型可注射药物的尿道导管套装用于透明质酸给药的患者满意度和可行性：一项多中心随机试验

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-024-84164-y

Kim, Sung Jin; Chae, Han Kyu; Nam, Wook; Park, Jong Yeon; Park, Sang Hyun; Chung, Jae-Seung; Oh, Cheol Kyu; Yoo, Sangjun; Cho, Min Chul; Jeong, Hyeon; Kim, Seong Cheol; Park, Sungchan; Seo, Won Ik; Chung, Jae Il; Lee, Chan Ho; Min, Kweonsik; Choi, Jimin; Suh, Jungyo; Lim, Bumjin; You, Dalsan

发表日期：2025

文献求助收藏

PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals

PTK2 是一种潜在的生物标志物和治疗靶点，可通过调节 EGFR 和 TLR 介导的信号通路之间的相互作用，参与 EGFR 或 TLR 诱导的肺癌进展。

期刊:Biomarker Research

影响因子:11.5

doi:10.1186/s40364-024-00604-x

Kim, Ji Young; Shin, Ji Hye; Kim, Mi-Jeong; Choi, Bongkum; Kang, Yeeun; Choi, Jimin; Kim, Seo Hyun; Kwan, Dohee; Kim, Duk-Hwan; Chun, Eunyoung; Lee, Ki-Young

Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study

卡非佐米、来那度胺和地塞米松联合疗法治疗复发/难治性多发性骨髓瘤患者可获得更佳疗效并改善高危因素：多中心 KMMWP2201 研究结果

期刊:Haematologica

影响因子:7.9

doi:10.3324/haematol.2024.285534

Lee, Ji Hyun; Choi, Jimin; Min, Chang-Ki; Park, Sung-Soo; Jo, Jae-Cheol; Lee, Yoo Jin; Kim, Jin Seok; Eom, Hyeon-Seok; Jung, Jongheon; Moon, Joon Ho; Cho, Hee Jeong; Lee, Myung-Won; Yoon, Sung-Soo; Byun, Ja Min; Lee, Jae Hoon; Lee, Je-Jung; Jung, Sung-Hoon; Shin, Ho-Jin; Kim, Do Young; Yi, Jun Ho; Lee, Seung-Shin; Do, Young Rok; Yoon, Dok Hyun; Cho, Hyungwoo; Lee, Won Sik; Lee, Ho Sup; Uhm, Jieun; Kim, Hyo Jung; Jang, Hee Ryeong; Kim, Sung-Hyun; Kim, Kihyun

Mexenone protects mice from LPS-induced sepsis by EC barrier stabilization

美西酮通过稳定 EC 屏障保护小鼠免受 LPS 诱发的脓毒症

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0302628

Yoon Ji Choi, Jimin An, Ji Hye Kim, Sa Bin Lee, Bo Seok Lee, Chae Young Eom, Hyohi Lee, Nayeong Kwon, Il Shin Kim, Kyoung-Su Park, Sooah Park, Jung-Woog Shin, Sanguk Yun

信号转导

发表日期：2024

文献求助收藏

Developing Problematic Performance Value Scores: Binding Routine Activity Performance, Environmental Barriers, and Health Conditions

制定问题绩效价值评分：将日常活动绩效、环境障碍和健康状况联系起来

期刊:International Journal of Environmental Research and Public Health

影响因子:

doi:10.3390/ijerph21060764

Choi, Jimin; Park, JiYoung

发表日期：2024

文献求助收藏

Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

基于癌症类器官的诊断反应性预测（CODRP）指数的抗癌药物敏感性测试在ALK重排阳性非小细胞肺癌（NSCLC）中的应用

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:12.8

doi:10.1186/s13046-023-02899-4

Lee, Sang-Yun; Cho, Hyeong Jun; Choi, Jimin; Ku, Bosung; Moon, Seok Whan; Moon, Mi Hyoung; Kim, Kyung Soo; Hyun, Kwanyong; Kim, Tae-Jung; Sung, Yeoun Eun; Hwang, Yongki; Lee, Eunyoung; Ahn, Dong Hyuck; Choi, Joon Young; Lim, Jeong Uk; Park, Chan Kwon; Kim, Sung Won; Kim, Seung Joon; Koo, In-Seong; Jung, Woo Seok; Lee, Sang-Hyun; Yeo, Chang Dong; Lee, Dong Woo

Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

更正：基于癌症类器官的诊断反应性预测（CODRP）指数的抗癌药物敏感性测试在ALK重排阳性非小细胞肺癌（NSCLC）中的应用

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:12.8

doi:10.1186/s13046-023-02919-3

Development of MDM2-Targeting PROTAC for Advancing Bone Regeneration.

开发MDM2靶向PROTAC以促进骨再生

USP11 promotes colorectal cancer progression by stabilizing EGFR and TRAF6: a potential therapeutic target in EGFR- and TLR-driven tumorigenesis.

USP11 通过稳定 EGFR 和 TRAF6 促进结直肠癌进展：EGFR 和 TLR 驱动的肿瘤发生的潜在治疗靶点。

PLA-Based Biodegradable Polymer from Synthesis to the Application

从合成到应用：基于PLA的生物降解聚合物

Patient satisfaction and feasibility with a novel drug-injectable urethral catheter set for hyaluronic acid administration: a multicenter randomized trial

一种新型可注射药物的尿道导管套装用于透明质酸给药的患者满意度和可行性：一项多中心随机试验

PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals

PTK2 是一种潜在的生物标志物和治疗靶点，可通过调节 EGFR 和 TLR 介导的信号通路之间的相互作用，参与 EGFR 或 TLR 诱导的肺癌进展。

Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study

卡非佐米、来那度胺和地塞米松联合疗法治疗复发/难治性多发性骨髓瘤患者可获得更佳疗效并改善高危因素：多中心 KMMWP2201 研究结果

Mexenone protects mice from LPS-induced sepsis by EC barrier stabilization

美西酮通过稳定 EC 屏障保护小鼠免受 LPS 诱发的脓毒症

Developing Problematic Performance Value Scores: Binding Routine Activity Performance, Environmental Barriers, and Health Conditions

制定问题绩效价值评分：将日常活动绩效、环境障碍和健康状况联系起来

Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

基于癌症类器官的诊断反应性预测（CODRP）指数的抗癌药物敏感性测试在ALK重排阳性非小细胞肺癌（NSCLC）中的应用

Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

更正：基于癌症类器官的诊断反应性预测（CODRP）指数的抗癌药物敏感性测试在ALK重排阳性非小细胞肺癌（NSCLC）中的应用